SevenBridge Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $886K | Sell |
6,669
-21
| -0.3% | -$2.94K | 0.14% | 125 |
|
|
2025
Q4 | $922K | Sell |
6,690
-50
| -0.7% | -$6.08K | 0.15% | 122 |
|
|
2025
Q3 | $832K | Sell |
6,740
-1,746
| -21% | -$198K | 0.14% | 123 |
|
|
2025
Q2 | $1.02M | Sell |
8,486
-210
| -2% | -$22.3K | 0.18% | 120 |
|
|
2025
Q1 | $903K | Sell |
8,696
-1,384
| -14% | -$143K | 0.18% | 125 |
|
|
2024
Q4 | $969K | Hold |
10,080
| – | – | 0.18% | 113 |
|
|
2024
Q3 | $978K | Hold |
10,080
| – | – | 0.19% | 109 |
|
|
2024
Q2 | $748K | Sell |
10,080
-230
| -2% | -$15.3K | 0.17% | 117 |
|
|
2024
Q1 | $668K | Sell |
10,310
-2,875
| -22% | -$221K | 0.15% | 122 |
|
|
2023
Q4 | $1.07M | Sell |
13,185
-782
| -6% | -$60.9K | 0.25% | 92 |
|
|
2023
Q3 | $1.05M | Buy |
13,967
+2,600
| +23% | +$200K | 0.27% | 90 |
|
|
2023
Q2 | $876K | Buy |
11,367
+1,847
| +19% | +$147K | 0.23% | 100 |
|
|
2023
Q1 | $790K | Buy |
9,520
+530
| +6% | +$43.9K | 0.22% | 104 |
|
|
2022
Q4 | $772K | Buy |
8,990
+245
| +3% | +$19.4K | 0.23% | 104 |
|
|
2022
Q3 | $539K | Buy |
+8,745
| New | +$551K | 0.18% | 103 |
|
|
2020
Q3 | – | Sell |
-2,667
| Closed | -$205K | – | 136 |
|
|
2020
Q2 | $205K | Buy |
+2,667
| New | +$204K | 0.1% | 130 |
|
|
2019
Q4 | – | Sell |
-3,192
| Closed | -$202K | – | 153 |
|
|
2019
Q3 | $202K | Sell |
3,192
-275
| -8% | -$18K | 0.11% | 139 |
|
|
2019
Q2 | $234K | Sell |
3,467
-169
| -5% | -$11.1K | 0.08% | 140 |
|
|
2019
Q1 | $236K | Buy |
3,636
+315
| +9% | +$20.9K | 0.09% | 128 |
|
|
2018
Q4 | $208K | Sell |
3,321
-1,030
| -24% | -$72K | 0.13% | 115 |
|
|
2018
Q3 | $336K | Sell |
4,351
-86
| -2% | -$6.5K | 0.18% | 95 |
|
|
2018
Q2 | $314K | Sell |
4,437
-270
| -6% | -$19.1K | 0.17% | 100 |
|
|
2018
Q1 | $355K | Sell |
4,707
-155
| -3% | -$12.3K | 0.2% | 97 |
|
|
2017
Q4 | $348K | Buy |
4,862
+270
| +6% | +$20.5K | 0.19% | 103 |
|
|
2017
Q3 | $372K | Buy |
4,592
+1,445
| +46% | +$110K | 0.21% | 99 |
|
|
2017
Q2 | $223K | Sell |
3,147
-650
| -17% | -$43.3K | 0.14% | 129 |
|
|
2017
Q1 | $253K | Sell |
3,797
-5,266
| -58% | -$370K | 0.17% | 114 |
|
|
2016
Q4 | $662K | Hold |
9,063
| – | – | 0.48% | 61 |
|
|
2016
Q3 | $662K | Buy |
9,063
+6,918
| +323% | +$562K | 0.48% | 61 |
|
|
2016
Q2 | $179K | Buy |
+2,145
| New | +$190K | 0.13% | 148 |
|
Other funds holding GILD
VCM
VPM
SevenBridge Financial Group's GILD Position: Q1 2026 in Review
SevenBridge Financial Group reduced its Gilead Sciences (GILD) stake by 0.31% in Q1 2026, selling an estimated $2.94K and leaving 6,669 shares worth $886K. The position accounts for 0.14% of the portfolio, ranked #125.
SevenBridge Financial Group first reported a position in GILD in Q2 2016 and has held it in 30 quarters since. The position peaked at $1.07M in Q4 2023. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- SevenBridge Financial Group held 6,669 shares of Gilead Sciences worth $886K as of Q1 2026.
- SevenBridge Financial Group sold 21 Gilead Sciences shares in Q1 2026, an estimated $2.94K.
- Gilead Sciences made up 0.14% of SevenBridge Financial Group's portfolio in Q1 2026, its #125 holding.
- SevenBridge Financial Group first reported a position in Gilead Sciences in Q2 2016 and has held it in 30 quarters since.
- SevenBridge Financial Group's Gilead Sciences position peaked at $1.07M in Q4 2023.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.